Specialty code 183500000X · Sacramento, CA
NPI
1689149437
Since 2018
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
6600 Bruceville Rd
Sacramento, CA, 95823
Phone (916) 525-4920
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$317K
3,085 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Morgan Sato prescribed most often to Medicare patients was Atorvastatin Calcium, with 416 prescriptions and refills. In total Morgan Sato wrote 3,085 Medicare prescriptions that cost $317K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 416 | 1,383 | 188 | $5,088 |
| Metformin Hcl Er Metformin Hcl | 292 | 948 | 128 | $2,955 |
| Glipizide Generic | 267 | 884 | 128 | $3,411 |
| Metformin Hcl Generic | 253 | 831 | 113 | $3,154 |
| Jardiance Empagliflozin | 163 | 492 | 66 | $80K |
| Lisinopril Generic | 134 | 447 | 57 | $1,657 |
| Insulin Glargine-Yfgn Generic | 132 | 373 | 69 | $23K |
| Amlodipine Besylate Generic | 126 | 417 | 60 | $1,573 |
| Losartan Potassium Generic | 107 | 354 | 46 | $1,305 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 107 | 293 | 54 | $2,586 |
| Humulin N Insulin Nph Human Isophane | 103 | 315 | 57 | $21K |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 98 | 287 | 47 | $2,215 |
| Simvastatin Generic | 71 | 237 | 33 | $825 |
| Victoza 2-Pak Liraglutide | 70 | 74 | 22 | $44K |
| Humulin R Insulin Regular, Human | 60 | 167 | 24 | $8,958 |
Brand drugs: 748 claims; generic drugs: 2,033 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Morgan Sato were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.